Indogulf Cropsciences Ltd will engage with analysts and investors through one-on-one and group interactions on June 18 and June 19, 2026, in Mumbai. The discussions will be based on generally available information and will not relate to any Unpublished Price Sensitive Information (UPSI).

The company intimated the stock exchanges regarding the schedule pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was read with Part A of Schedule III of the regulations.

The following table details the scheduled meetings with various investment firms:

Sanjay Aggarwal, Managing Director of Indogulf Cropsciences Ltd, signed the intimation dated June 15, 2026.

Indogulf Cropsciences Limited reported a 27.3% year-on-year rise in consolidated net profit to ₹400.27 crore for the financial year ended March 31, 2026. Revenue from operations for the year grew 19.3% to ₹7,046.33 crore, driven by distribution expansion and export growth. For the quarter ended March 31, 2026, net profit stood at ₹116.12 crore, while revenue was ₹1,508.18 crore. The company’s EBITDA for FY26 increased 15% to ₹740 crore, with margins at 10.4%.

The Board of Directors, in its meeting held on May 28, 2026, approved the audited standalone and consolidated financial results. Devesh Parekh & Co., Chartered Accountants, issued an unmodified opinion on the results. The board recommended the appointment of M/s NJ & Associates as Secretarial Auditors for a term of five years commencing from FY 2026-27, subject to shareholder approval. Additionally, the board appointed M/s Jain Sharma & Associates as Cost Auditors and M/s T Jain and Associates as Internal Auditors for FY 2026-27.

Key Financial Metrics

Strategic Outlook

The company outlined its strategy to evolve from an agrochemical company into an integrated agri-solutions platform. Key focus areas include increasing the contribution of high-margin specialty products, strengthening operational excellence through procurement and supply chain efficiency, and expanding its portfolio of biologicals and sustainable crop solutions. Indogulf aims to accelerate global expansion by entering new markets and significantly growing export revenues, supported by 990 total registrations across various geographies.

Operational Highlights

Indogulf’s manufacturing capabilities are spread across four facilities located in Nathupur (I & II), Barwasni, and Samba, with a total capacity exceeding 44,000 MT/KL/TPA. The company reported a capacity utilization rate of 52% for FY26. Its diversified product portfolio spans crop protection (85% of revenue share), plant nutrients (5%), and biologicals (6%). The company also emphasized its deepening farmer engagement model, which includes product demonstrations, advisory-led consultations, and field trials to drive long-term value creation.

Business Performance

The company expanded its export presence with entry into newer geographies including Venezuela, Taiwan, and Sudan, marking its entry into the Latin American market with a fertilizer shipment to Venezuela. Distribution strength was bolstered by a network of 7,000+ distributors and 192 active institutional business partners. Additionally, Indogulf signed a MoA under the Prime Minister's Fellowship for Doctoral Research with ICAR-IARI to support research-led agricultural innovation.

Sanjay Aggarwal, Managing Director, Indogulf Cropsciences Ltd, stated that the company delivered resilient growth supported by disciplined execution and improving product mix. He highlighted the expansion into Latin America and the scaling of operations by AGPL. Aggarwal noted that while the industry environment remains dynamic due to weather-related uncertainties and raw material volatility, the company is proactively managing procurement and supply chain operations. He added that capacity utilization improved steadily during the year, supported by better operational efficiencies.